Design Therapeutics, Inc. · NASDAQ:DSGN

Point72 Asset Management, L.P. reported a 9.40% stake in Design Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Point72 Asset Management, L.P. reported a 9.40% stake in Design Therapeutics, Inc., 5,372,004 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.40%
Shares
5,372,004
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.9.40%5,372,004
Point72 Capital Advisors, Inc.9.40%5,372,004
Steven A. Cohen9.40%5,372,004

Source

View original at SEC

Related